By Business/Source
Currency:USD
2026/Q1
Stock NameRevenueRatio
Developing, manufacturing and commercializing medicines designed to address unmet medical needs of392.91M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
U.S.1.37B93.01%
Rest of world102.36M6.94%
Ireland754K0.05%